Organome, a company from Baltimore in the United States, hopes to artificially produce mini brains that can be used in research. The mini-brains produced by organoids are not the first, but those generated to date have been too small for experimental use, since they do not measure more than 5 mm wide and it also takes several months to produce them; moreover, they contain very variable amounts of cells, which is an objective drawback for their experimental use. The organoids now produced by Organome measure 350 mm wide and have roughly the same number of cells. Additionally, using in-house technical methods, the organoids can be obtained in 10 weeks, and have a very similar cell composition. The company hopes to be able to have these mini-brains on the market next September. A European collaborator of Organome, Atera, is also thinking of producing organoids of human epidermis. Organome is the parent company located in the United States, while Atera will be its European branch (Nature Medicine 22; 338, 2016).
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.